IMPAVIDO
miltefosine
Listed by Profounda, Inc.
- Strength
- 50 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Antileishmanial
What it contains
- Miltefosine 50 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Antileishmanial |
| Approval route | NDA — original brand approval |
| NDC code | 69051-300 |
| FDA application | NDA204684 |
| RxNorm concept | 1494071 |
| Package sizes listed | 1 |
| Marketed since | October 2015 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.